^
Association details:
| Biomarker: | HER-2 negative |
|---|---|
| Cancer: | Esophageal Squamous Cell Carcinoma |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Principles of Systemic Therapy for Unresectable Locally Advanced, Recurrent or Metastatic Disease...First-line Therapy...Preferred Regimens...HER2 overexpression negative...Fluoropyrimidine (fluorouracil or capecitabine), oxaliplatin, and nivolumab for squamous cell carcinoma...Fluoropyrimidine (fluorouracil or capecitabine), cisplatin, and nivolumab for squamous cell carcinoma
Secondary therapy:
capecitabine + oxaliplatin; cisplatin + 5-fluorouracil; cisplatin + capecitabine; 5-fluorouracil + oxaliplatin
